Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relugolix in uterine fibroids pain
NCT02655224Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2016
- Primary completion
- May 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of relugolix in Uterine Fibroids (UF), sponsored by Takeda. Started Mar 2016; status: completed.
02
Drugs
relugolix
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT02655224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02655224.